Showing results (331-340 of 386) with videos related to

Sort By:
Pageof 39
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 3, 2022
Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic AdenocarcinomaA V Reddy, C S Hill, S Sehgal, et al.
Cellular and Molecular Life Sciences : CMLS|September 25, 2003
Pharmacogenetics and disease genetics of complex diseasesV D Schmith, D A Campbell, S Sehgal, et al.
Indian Journal of Pathology & Microbiology|July 1, 1990
HIV-I antibodies in health and diseaseS Sehgal, B Kumar, M Singh, et al.
Mycoses|December 12, 2022
Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysisInderpaul S Sehgal, Sahajal Dhooria, Valliappan Muthu, et al.
Diagnostics (Basel, Switzerland)|February 11, 2023
Ultra-Low Dose CT Chest in Acute COVID-19 Pneumonia: A Pilot Study from IndiaMandeep Garg, Shritik Devkota, Nidhi Prabhakar, et al.
Mycoses|August 16, 2016
Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosisRitesh Agarwal, Devika Dua, Hansraj Choudhary, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 31, 2025
Validation of the Bronchiectasis Health Questionnaire in Bronchiectasis and Estimation of the Meaningful Score Difference for ABPAPratibha Jha, Surinder S Birring, Inderpaul S Sehgal, et al.
Yeast (Chichester, England)|February 25, 1999
Asymmetric distribution of phosphatidylethanolamine in C. albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamilyS Dogra, S Krishnamurthy, V Gupta, et al.
The Journal of Biological Chemistry|August 10, 1982
The site of attachment of retinal in bacteriorhodopsin. The epsilon-amino group in Lys-41 is not required for proton translocationK S Huang, M J Liao, C M Gupta, et al.
Anticancer Research|April 20, 2006
Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126George W Cole, Annette M Alleva, Jing T Zuo, et al.
Pageof 39